• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西南部人群中DPYD基因变异的频率及表型推断

Frequency of DPYD gene variants and phenotype inference in a Southern Brazilian population.

作者信息

Botton Mariana Rodrigues, Hentschke-Lopes Marina, Matte Ursula

机构信息

Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

Cells, Tissues and Genes Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.

出版信息

Ann Hum Genet. 2022 Mar;86(2):102-107. doi: 10.1111/ahg.12453. Epub 2021 Dec 13.

DOI:10.1111/ahg.12453
PMID:34897655
Abstract

Fluoropyrimidines are chemotherapy drugs that may cause severe adverse events, and their metabolism occurs by dihydropyrimidine deydrogenase (DPD), coded by DPYD. Variants in the DPYD were associated to a greater risk of toxicity. Our aim was to determine the frequency of the most relevant DPYD alleles according to CPIC guidelines (DPYD2A-rs3918290, DPYD13-rs55886062, rs67376798, and HapB3-rs75017182) in a sample of 800 healthy Southern Brazilians. Frequencies for rs3918290, rs75017182, and rs67376798 were 0.25%, 1.06%, and 0.38%, respectively. No rs55886062 allele was detected. In total, 3.4% of individuals were classified as intermediate metabolizers. Frequencies for rs3918290, rs55886062, and rs67376798 were similar to those found in non-Finnish Europeans; however, rs75017182 was less frequent when compared to non-Finnish Europeans, but more frequent than in Africans and East Asians. rs3918290 and rs67376798 also presented higher frequency when compared to Africans. The Latino population was the only one that did not differ from our sample in any variant analyzed. The frequencies for all the other populations (non-Finnish European, African, South Asian, and East Asian) presented differences from our sample in at least one variant. rs115232898 was not analyzed in the present study. Cost-effective studies should be performed to evaluate the implementation of these tests in the clinical practice in the Southern Brazil.

摘要

氟嘧啶是可能导致严重不良事件的化疗药物,其代谢由二氢嘧啶脱氢酶(DPD,由DPYD编码)进行。DPYD基因变异与更高的毒性风险相关。我们的目的是根据CPIC指南(DPYD2A-rs3918290、DPYD13-rs55886062、rs67376798和HapB3-rs75017182),在800名巴西南部健康人群样本中确定最相关的DPYD等位基因频率。rs3918290、rs75017182和rs67376798的频率分别为0.25%、1.06%和0.38%。未检测到rs55886062等位基因。总体而言,3.4%的个体被归类为中间代谢者。rs3918290、rs55886062和rs67376798的频率与在非芬兰欧洲人中发现的频率相似;然而,与非芬兰欧洲人相比,rs75017182的频率较低,但比非洲人和东亚人更常见。与非洲人相比,rs3918290和rs67376798也表现出更高的频率。拉丁裔人群是在任何分析的变异中与我们的样本没有差异的唯一群体。所有其他人群(非芬兰欧洲人、非洲人、南亚人和东亚人)的频率在至少一个变异中与我们的样本存在差异。本研究未分析rs115232898。应进行成本效益研究,以评估在巴西南部临床实践中实施这些检测的情况。

相似文献

1
Frequency of DPYD gene variants and phenotype inference in a Southern Brazilian population.巴西南部人群中DPYD基因变异的频率及表型推断
Ann Hum Genet. 2022 Mar;86(2):102-107. doi: 10.1111/ahg.12453. Epub 2021 Dec 13.
2
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.基于二氢嘧啶脱氢酶(DPYD)的药物遗传学检测预测氟嘧啶类药物严重毒性的临床有效性。
Int J Cancer. 2015 Dec 15;137(12):2971-80. doi: 10.1002/ijc.29654. Epub 2015 Jul 14.
3
Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study.西班牙癌症患者中 DPYD 基因变异的等位基因频率:PhotoDPYD 研究。
Oncologist. 2023 May 8;28(5):e304-e308. doi: 10.1093/oncolo/oyad077.
4
Pharmacogenetics of DPYD and treatment-related mortality on fluoropyrimidine chemotherapy for cancer patients: a meta-analysis and trial sequential analysis.DPYD 药物遗传学与癌症患者氟嘧啶化疗相关死亡率:荟萃分析和试验序贯分析。
BMC Cancer. 2024 Sep 30;24(1):1210. doi: 10.1186/s12885-024-12981-5.
5
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.基于 DPYD 基因型的氟嘧啶类药物个体化剂量在癌症患者中的应用:一项前瞻性安全性分析。
Lancet Oncol. 2018 Nov;19(11):1459-1467. doi: 10.1016/S1470-2045(18)30686-7. Epub 2018 Oct 19.
6
Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5-fluorouracil toxicity.单倍型结构定义了常见的二氢嘧啶脱氢酶(DPYD)基因变异c.85T>C(rs1801265)和c.496A>G(rs2297595)对二氢嘧啶脱氢酶活性的影响:对5-氟尿嘧啶毒性的启示。
Br J Clin Pharmacol. 2021 Aug;87(8):3234-3243. doi: 10.1111/bcp.14742. Epub 2021 Mar 30.
7
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: genotyping to guide chemotherapy dosing in Greece.在接受氟嘧啶治疗的癌症患者中实施药物遗传学检测:希腊的基因分型以指导化疗剂量调整
Front Pharmacol. 2023 Sep 14;14:1248898. doi: 10.3389/fphar.2023.1248898. eCollection 2023.
8
Diversity of oncopharmacogenetic profile within Spanish population.西班牙人群的肿瘤遗传药理学特征多样性。
Pharmacogenet Genomics. 2024 Jul 1;34(5):166-169. doi: 10.1097/FPC.0000000000000530. Epub 2024 Mar 18.
9
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.在高危结肠癌患者的随机III期辅助TOSCA试验中,二氢嘧啶脱氢酶药物遗传学用于预测氟嘧啶相关毒性。
Br J Cancer. 2017 Oct 24;117(9):1269-1277. doi: 10.1038/bjc.2017.289. Epub 2017 Aug 24.
10
Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy.氟嘧啶类化疗:瑞士药物基因组学和个体化治疗小组的 DPYD 基因分型和治疗药物监测建议。
Swiss Med Wkly. 2020 Nov 24;150:w20375. doi: 10.4414/smw.2020.20375. eCollection 2020 Nov 16.

引用本文的文献

1
Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer: A Secondary Analysis of the PREPARE Randomized Clinical Trial.治疗前DPYD和UGT1A1检测在胃肠道癌中的临床益处及应用:PREPARE随机临床试验的二次分析
JAMA Netw Open. 2024 Dec 2;7(12):e2449441. doi: 10.1001/jamanetworkopen.2024.49441.
2
Assessing the Occurrence and Influence of Cancer Chemotherapy-Related Pharmacogenetic Alleles in the Chilean Population.评估智利人群中癌症化疗相关药物遗传学等位基因的发生情况及其影响。
Pharmaceutics. 2024 Apr 19;16(4):561. doi: 10.3390/pharmaceutics16040561.
3
Genetic Variations of the Gene and Its Relationship with Ancestry Proportions in Different Ecuadorian Trihybrid Populations.
厄瓜多尔不同三杂交群体中该基因的遗传变异及其与祖先比例的关系。
J Pers Med. 2022 Jun 10;12(6):950. doi: 10.3390/jpm12060950.